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Several developmental pathways contribute to pro-
cesses that regulate tissue growth and organ size.
The Hippo pathway has emerged as one such critical
regulator. However, how Hippo signaling is inte-
grated with other pathways to coordinate these pro-
cesses remains unclear. Here, we show that the
Hippo pathway restricts Wnt/b-Catenin signaling by
promoting an interaction between TAZ andDVL in the
cytoplasm. TAZ inhibits the CK1d/3-mediated phos-
phorylation of DVL, thereby inhibiting Wnt/b-Catenin
signaling. Abrogation of TAZ levels orHippo signaling
enhances Wnt3A-stimulated DVL phosphorylation,
nuclear b-Catenin, and Wnt target gene expression.
Mice lacking Taz develop polycystic kidneys with
enhanced cytoplasmic and nuclear b-Catenin. More-
over, in Drosophila, Hippo signaling modulates Wg
target geneexpression. These results uncover acyto-
plasmic function of TAZ in regulating Wnt signaling
and highlight the role of the Hippo pathway in coordi-
nating morphogenetic signaling with growth control.
INTRODUCTION
Animal development requires the coordination of cell patterning
events with growth and proliferation signals to insure appropriate
organ architecture and size. These types of developmental
processes require precise cell-cell communication, which, if
misregulated, can result in pathological disorders such as
cancer. Secreted factors facilitate cell-cell communication and
provide a mechanism for spatial and temporal control during
development. Wnts comprise one such family of secreted
proteins and act as morphogens to control cell fate, differentia-
tion, and proliferation. Wnts bind to cell-surface Frizzled
and LRP receptors and thereby stimulate diverse biological
responses (Clevers, 2006; Nusse, 2005). At the core of theDevecanonical Wnt pathway is the transcriptional regulator
b-Catenin. In the absence of Wnt stimulation, b-Catenin levels
are kept low by proteasome-mediated degradation (Aberle
et al., 1997). Activation of Wnt signaling induces the hyperphos-
phorylation of Dishevelled (DVL), and this, via a poorly under-
stood mechanism, ultimately leads to a rise in b-Catenin levels
and to the activation of b-Catenin target genes (Clevers, 2006;
Nusse, 2005). Given that aberrant activation of canonical Wnt
signaling disrupts development and promotes tumorigenesis,
understanding the mechanisms that normally function to restrict
these signals is critical.
The precise control of organ size requires appropriate
signaling via the Hippo pathway, which plays a key role in
controlling cell proliferation and apoptosis (Saucedo and Edgar,
2007; Zhao et al., 2008). Central to this pathway is a kinase
cascade in which the Ste20-like kinases MST1 and MST2
(Hippo/Hpo in Drosophila) phosphorylate and activate the NDR
family kinases, LATS1 and LATS2 (Warts/Wts in Drosophila)
(Chan et al., 2005). LATS kinases subsequently phosphorylate
the transcriptional regulators TAZ and YAP (Yorkie/Yki in
Drosophila) (Dong et al., 2007; Lei et al., 2008). Phosphorylation
of TAZ and YAP promotes their interaction with 14-3-3 proteins
and results in their cytoplasmic retention (Basu et al., 2003;
Kanai et al., 2000). In the nucleus, TAZ and YAP can associate
with a number of developmentally important proteins to mediate
the transcription of genes that control cell proliferation and
apoptosis, stem cell maintenance, and differentiation (Saucedo
and Edgar, 2007; Zhao et al., 2008). More recently, other
functions for TAZ and YAP have emerged. For example, TAZ
regulates the nuclear localization of TGFb-regulated Smad tran-
scription factors (Varelas et al., 2008) and can regulate SCF
ubiquitin ligases (Tian et al., 2007). Studies in mice have shown
that Taz and Yap can have unique roles in vivo, as Taz/ mice
develop polycystic kidney disease (PKD) and emphysema
(Hossain et al., 2007; Makita et al., 2008; Tian et al., 2007),
whereas Yap/ mice display embryonic lethality at embryonic
day 8.5 (E8.5), with defects in yolk sac vasculogenesis, chorioal-
lantoic attachment, and embryonic axis elongation (Morin-
Kensicki et al., 2006). However, clear evidence for Taz/Yap
functional redundancy has been provided by the observationlopmental Cell 18, 579–591, April 20, 2010 ª2010 Elsevier Inc. 579
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(Nishioka et al., 2009).
Here, we demonstrate that TAZ, an integral member of the
Hippo pathway, binds DVL and negatively regulates the Wnt
pathway. We show that loss of TAZ increases DVL2 phosphory-
lation and Wnt-dependent b-Catenin activation, resulting in
enhanced cytoplasmic and nuclear b-Catenin accumulation in
cell culture and in the kidneys of Taz-null mice. Furthermore,
loss of Hippo pathway activity leads to increased nuclear TAZ
and reduced TAZ-DVL binding, which results in increased
Wnt-stimulated DVL2 phosphorylation, b-Catenin nuclear accu-
mulation, and induction of Wnt-target genes. As in mammalian
cells, we show that the Hippo pathway negatively regulates
Wingless (Wg) signaling in Drosophila imaginal discs. These
studies reveal a conserved function for the Hippo pathway in
modulating Wnt signaling via TAZ, and provide insight into how
morphogen signaling is coordinated with pathways that control
tissue growth.
RESULTS
TAZ Is a Negative Regulator of Wnt/b-Catenin Signaling
To identify novel Wnt/b-Catenin pathway components, we
implemented a multidimensional screening approach to query
the contribution to the Wnt pathway of a focused subset of 640
genes enriched in intracellular signaling components (Barrios-
Rodiles et al., 2005; Miller et al., 2009). For this, we used three
mammalian cell-based high-throughput assays that included
the LUMIER protein-protein interaction assay (Barrios-Rodiles
et al., 2005) and two screens examining how overexpression
versus siRNA-mediated gene knockdown affected Wnt3A-
dependent induction of the transcriptional reporter TOPflash
(Miller et al., 2009). Meta-analysis of these data uncovered the
transcriptional regulator TAZ as a regulator of Wnt/b-Catenin
signaling. Specifically, we observed that siRNA-mediated
knockdown of TAZ enhanced Wnt3A-induced TOPflash activity,
and that TAZ strongly associated with DVL2 in LUMIER (see
Figure S1 available online). Accordingly, we demonstrated that
RNAi-mediated knockdown of endogenous TAZ expression in
HEK293T cells, using either a pool or a distinct single siRNA,
enhanced TOPflash reporter activity, but not that of the nonre-
sponsive FOPflash control reporter (Figures 1A; Figure S1C).
Expression of low levels of siRNA-resistant mouse Taz rescued
the siTAZ-mediated increase of TOPflash reporter activity in
the human HEK293T cells, confirming the specificity of the TAZ
siRNA (Figure 1B). We also examined endogenous Wnt signaling
by using the Wnt-responsive breast cancer cell line, MDA-MB-
231. Quantitative real-time PCR analysis revealed that knock-
down of TAZ in MDA-MB-231 cells enhanced Wnt3A-induced
AXIN2, NKD1, and TNFRSF19 expression (Figure 1C). Moreover,
TAZ knockdown increased endogenous b-Catenin protein levels
(Figure 1D) and enhanced nuclear accumulation of b-Catenin
after Wnt3A stimulation (Figure 1E). Collectively, these results
show that TAZ is a negative regulator of the Wnt pathway.
Taz Mutant Kidneys Display Enhanced Cytoplasmic
and Nuclear b-Catenin Localization
Taz-null mice develop severe renal cysts (Hossain et al., 2007;
Makita et al., 2008; Tian et al., 2007) that resemble those formed580 Developmental Cell 18, 579–591, April 20, 2010 ª2010 Elsevier Iin human PKD. Excessive Wnt signaling in mouse kidneys, as the
result of either ectopic expression of an activated mutant of
b-Catenin or via loss of Apc, also yields polycystic kidney lesions
(Saadi-Kheddouci et al., 2001; Sansom et al., 2005). Moreover,
cysts from patients with autosomal dominant PKD (ADPKD)
display a gene signature indicative of activated Wnt signaling
(Lal et al., 2008). We therefore generated Taz mutant mice by
using a genetrap (gt) line (Figure S2), and we examined the local-
ization of b-Catenin in kidney sections from wild-type (WT) and
Tazgt/gt mouse embryos by confocal microscopy. In Tazgt/gt
mice, renal cysts were first detected at around E15–16, consis-
tent with other Taz mutant mice (Hossain et al., 2007). Therefore,
we first examined b-Catenin localization at the onset of cyst
formation at E15 (Figure 2A). In epithelial structures of WT
kidneys, b-Catenin was predominantly localized in junctions,
although in some cells b-Catenin was also localized in the
cytoplasm. In Tazgt/gt kidneys, b-Catenin displayed prominent
cytoplasmic and nuclear localization in tubules that otherwise
displayed normal morphology. Next, we analyzed cysts in E16
and E17 embryos. Unlike WT kidneys, where b-Catenin was
strongly junctional, with little or no nuclear localization, Tazgt/gt
kidneys displayed prominent cytoplasmic and nuclear localiza-
tion of b-Catenin (Figure 2A). Similar redistribution of b-Catenin
was also observed in E18.5 kidneys derived from a distinct
Taz-null line (Hossain et al., 2007); data not shown). Quantitation
of b-Catenin localization from a series of random images
obtained from regions near the renal cortex of WT and Tazgt/gt
kidneys revealed that from E15 to E17 80% of Tazgt/gt tubules
displayed cytoplasmic and/or nuclear b-Catenin as compared to
40%–60% of tubules from WT mice (Figure 2B). Strikingly, as
the Tazgt/gt mutants progressed from E15 to E17, 15% of their
tubules displayed predominantly nuclear b-Catenin, whereas
virtually no WT structures (1%) displayed this localization
pattern. These observations demonstrate that interfering with
Taz in the kidney leads to increased cytoplasmic and nuclear
b-Catenin, supporting the notion that Taz is a negative regulator
of the canonical WNT pathway in vivo.
TAZ Inhibits Wnt3A-Induced Phosphorylation of DVL2
To gain insight into the mechanism of the inhibitory activity of
TAZ on Wnt signaling, we focused on investigating the associa-
tion of TAZ with DVL that was first revealed in our LUMIER screen
(Figure S1). Immunoprecipitation of Flag-tagged DVL1, DVL2, or
DVL3 followed by immunoblotting for HA-tagged TAZ revealed
that TAZ interacted with all three DVL isoforms, with a preference
for DVL2 (Figure 3A). Endogenous TAZ and DVL2 also interacted
in both MDA-MB-231 and HEK293T cells (Figure 3B; data not
shown). To map the determinants of the interaction, TAZ deletion
mutants were tested for interaction with DVL2 by LUMIER. This
revealed that the WW domain and the carboxy-terminal PDZ-
binding motif of TAZ both contribute to the association of TAZ
with DVL2 (Figure 3C). Conversely, analysis of the binding of
a series of DVL2 mutants to TAZ demonstrated that the PDZ
domain and a PY motif located at amino acids 564–568 both
contribute to the interaction (Figure 3D). Importantly, deletion
of the WW domain and PDZ-binding motif of TAZ did not affect
interaction with another known interactor, b-TrCP (Figure S3).
Wnt3A induces DVL phosphorylation, an event that preceeds
b-Catenin stabilization and activation (Wallingford and Habas,nc.
Figure 1. TAZ is a Negative Regulator of the Wnt/b-Catenin Pathway
(A) TAZ knockdown enhances Wnt3A-induced activity of the TOPflash reporter. TOPflash reporter activity was measured in HEK293T cells transfected with
increasing amounts (25 nM or 50 nM) of pooled or single TAZ siRNA (siTAZ) or a scrambled control (siCTL), and then treated with control or Wnt3A-conditioned
media.
(B) siRNA-resistant TAZ rescues enhanced Wnt signaling resulting from TAZ knockdown. TOPflash and FOPflash reporter activity was measured in HEK293T
cells transfected with siCTL or siTAZ expressing very low levels of siRNA-resistant mouse Taz and after treatment with control of Wnt3A-conditioned media.
The relative levels of mouse and human TAZ were measured by quantitative RT-PCR in parallel samples.
(C) TAZ knockdown induces Wnt3A-dependent target gene expression. The expression of NKD1, TNFRSF19, and AXIN2 was determined by qPCR from MDA-
MB-231 cells transfected with siTAZ or siCTL and treated for 4 or 16 hr with control or Wnt3A-conditioned media as indicated.
(D) TAZ knockdown stabilizes b-Catenin levels. MDA-MB-231 cells were transfected with siTAZ or siCTL and treated with control or Wnt3A-conditioned media for
4 hr, and total cell lysates were subsequently analyzed for b-Catenin levels by immunoblotting.
(E) Knockdown of TAZ induces nuclear b-Catenin accumulation. MDA-MB-231 cells were transfected with siTAZ or siCTL and treated with control or Wnt3A-
conditioned media for 2 hr. Cells were then analyzed for endogenous b-Catenin localization by immunofluorescent microscopy. The scale bar represents
10 mM. The percentage of cells displaying high nuclear/cytoplasmic variance of b-Catenin signal is shown. Data show that after Wnt3A treatment, siTAZ-treated
cells displayed high nuclear/cytoplasmic variance (p < 0.0001).
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phosphorylation. Knockdown of TAZ expression in MDA-MB-
231 cells increased phosphorylation of endogenous DVL2 thatDevewas further enhanced by Wnt3A stimulation (Figure 4A). CK13,
and the highly related CK1d, have been shown to mediate Wnt-
induced DVL phosphorylation (McKay et al., 2001). Therefore,lopmental Cell 18, 579–591, April 20, 2010 ª2010 Elsevier Inc. 581
Figure 2. Mislocalization of b-Catenin in Kidney Cysts of Tazgt/gt Mouse Embryos
(A) Kidney sections from E15, E16, or E17 WT or Tazgt/gt mice were analyzed by immunostaining for b-Catenin. Higher-magnification images of boxed sections are
shown. The cell nuclei were visualized by DAPI staining. The scale bar represents 10 mM.
(B) b-Catenin localization was assessed in tubules from WT and Tazgt/gt embryonic kidneys and classified as junctional (junct), junctional/cytoplasmic/nuclear
(junct/cyto/nuc), or cytoplasmic/nuclear (cyto/nuc), with representative tubules marked as I, II, or III, respectively. The percentage of total tubules from E15,
E16, and E17 kidneys is shown after the quantitation of 193 WT and 187 Tazgt/gt tubules.
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dent DVL2 phosphorylation. Treatment of MDA-MB-231 cells
with a CK1d/3 inhibitor, IC261 (Mashhoon et al., 2000), efficiently
blocked Wnt-induced DVL phosphorylation, but resulted in only
a partial inhibition of b-Catenin stabilization. This suggests the
existence of both CK1d/3-dependent and -independent routes
to b-Catenin stabilization, as has been reported previously (Bryja
et al., 2007). Importantly, treatment of cells with IC261 blocked
siTAZ-induced DVL2 phosphorylation, both in the presence
and absence of Wnt3A treatment, and concomitantly reduced
siTAZ-induced b-Catenin stabilization (Figure 4A). Similarly,
targeting of endogenous CK1d/3 with siRNAs also prevented
the enhancement of DVL2 phosphorylation caused by TAZ
knockdown (Figure 4B). Moreover, blocking CK13 activity or
expression with IC261 or siRNA, respectively, reversed the
effect of siTAZ on Wnt3A-mediated activation of the TOPflash
reporter (Figure 4C; Figure S4A). Consistent with a role for TAZ
upstream of the b-Catenin destruction complex, siRNA-medi-
ated abrogation of TAZ expression had no effect on constitutive
TOPflash activity in SW480 or Colo205 colorectal cancer cells,
which harbor mutations in APC (Figure S4B). However, RKO
colon cancer cells, which retain WT APC, displayed increased
TOPflash activity after TAZ knockdown (Figure S4B). Altogether,
these results demonstrate that TAZ suppresses Wnt3A signaling
by limiting the ability of CK1d/3 to phosphorylate DVL2.
CK1d/3 bind to DVLs (McKay et al., 2001), thus we extended
our analysis to examine whether TAZ interferes with the CK1d/
3-DVL interaction. Indeed, expression of WT TAZ inhibited the
association of transfected CK1d/3 with DVL2 (Figure 4D). Simi-
larly, LUMIER analysis revealed that TAZ inhibited the interaction
of endogenous DVL2 with luciferase-tagged CK13, whereas
expression of the DVL2-binding mutant of TAZ (TAZ 1–393,
DWW) did not (Figure 4E). Thus, TAZ prevents CK1d/3 from asso-
ciating with and phosphorylating DVL2. To examine the effect of
the DVL-binding mutant of TAZ on Wnt signaling, we eliminated582 Developmental Cell 18, 579–591, April 20, 2010 ª2010 Elsevier Iendogenous TAZ expression by using siRNA and expressed
low levels of siRNA-resistant mouse Taz. Analysis of TOPflash
activation showed that WT Taz rescued the siTAZ-mediated
increase in TOPflash reporter activity, whereas the DVL2-binding
mutant (Taz 1-393, DWW) did not (Figure 4F). Of note, the Taz
S89A mutant, which is unable to bind to 14-3-3 proteins and is
localized predominantly in the nucleus, also failed to rescue
siTAZ enhancement of TOPflash activation (Figure 4F). Alto-
gether, these results demonstrate that TAZ functions in the cyto-
plasm to downregulate Wnt/b-Catenin signaling by binding DVL2
and preventing the phosphorylation by CK1d/3.
Hippo Signaling Promotes the Association
of Cytoplasmic TAZ with DVL2 to Downregulate
Wnt/b-Catenin Signaling
The activity of TAZ in restricting Wnt signaling suggests that
pathways that regulate TAZ may, in turn, modulate Wnt/b-Cate-
nin activity. InDrosophila, the Hpo/Wts kinase pathway regulates
the localization and activity of the TAZ/YAP homolog Yki, and
the orthologous mammalian MST/LATS pathway has been simi-
larly implicated in regulating TAZ and YAP function (Saucedo
and Edgar, 2007; Zhao et al., 2008). Therefore, we examined
whether this pathway influences TAZ function in Wnt/b-Catenin
signaling. In mammals, two Hpo kinase homologs, MST1 and
MST2, are upstream activators of the two Wts kinase homologs,
LATS1 and LATS2, which phosphorylate TAZ and YAP. Indeed,
LATS2 phosphorylates TAZ on serine 89 (Lei et al., 2008), and we
confirmed that LATS1 also phosphorylated TAZ on serine 89
(Figure S5). In addition, coexpression of the LATS1 activators
MST1 or MST2 further increased TAZ phosphorylation (Fig-
ure S5), and endogenous LATS1 and TAZ interacted in MDA-
MB-231 cells (Figure 5A). To examine if MST/LATS regulates
Wnt signaling, we employed siRNA to knock down LATS1,
LATS2, MST1, or MST2 and examined activation of the TOPflash
reporter in HEK293T cells. Efficient knockdown was confirmednc.
Figure 3. TAZ Binds to Dishevelled
(A) TAZ interacts with DVLs. HEK293T cells were transfected with HA-TAZ and Flag-DVL1, -2, or -3. After anti-Flag immunoprecipitation, the presence of TAZ was
detected by anti-HA immunoblotting.
(B) Interaction of endogenous TAZ and DVL2. Cell lysates from MDA-MB-231 cells were subjected to immunoprecipitation with anti-TAZ antibody or control IgG,
and the presence of DVL2 was examined by anti-DVL2 immunoblotting.
(C) DVL2 interacts with the WW domain and PDZ-binding motif of TAZ. HEK293T cells were cotransfected with the indicated Flag-TAZ WT or mutant constructs
and DVL2 tagged with Firefly luciferase. Cell lysates were subjected to anti-Flag immunoprecipitation, and the presence of DVL2 was assessed by luciferase
assay.
(D) TAZ interacts with the PY motif and PDZ domain of DVL2. HEK293T cells were cotransfected with the indicated Flag-DVL2 WT or mutant constructs and
HA-TAZ. Cell lysates were subjected to anti-Flag immunoprecipitation, and the presence of TAZ was assessed by anti-HA immunoblotting.
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shown). These analyses revealed that targeting any of the LATS
or MST kinases enhanced TOPflash activity, with the greatest
effects being observed upon knockdown of either LATS1 or
MST2 (Figure 5B). Because knockdown of both LATS1 and
LATS2 or both MST1 and MST2 did not further enhance TOP-
flash signaling, our results suggest that, in HEK293T cells,
MST2-LATS1 is the predominant kinase cascade regulating
Wnt. Consistent with our results, a genome-wide siRNA screen
also found that knockdown of LATS1 increased Wnt-induced
reporter activity (DasGupta et al., 2005). We next determined
the expression of the endogenous Wnt target gene, AXIN2, in
MDA-MB-231 cells. Similar to siTAZ (Figure 1C), siRNA-medi-Deveated knockdown of LATS1 or MST2 increased Wnt3A-depen-
dent AXIN2 expression (Figure 5C).
We next examined the effects of overexpressing MST/LATS,
which phosphorylates TAZ and thereby drives binding to
14-3-3 proteins and cytoplasmic retention of TAZ (Kanai et al.,
2000). This analysis revealed that overexpression of LATS1 or
MST2 alone reduced TOPflash, but not FOPflash, reporter
activity (Figure 5D; Figure S5B). Further reductions were
observed when LATS1 was coexpressed together with a WT,
but not a kinase-dead (K56R), version of MST2, its upstream acti-
vator (Figure 5D). Importantly, inhibition of TOPFlash activation
by MST/LATS was suppressed by TAZ knockdown (Figure 5E),
consistent with TAZ functioning downstream of MST/LATS inlopmental Cell 18, 579–591, April 20, 2010 ª2010 Elsevier Inc. 583
Figure 4. TAZ Inhibits DVL2 Phosphorylation by CK1d/3
(A and B) TAZ knockdown induces CK1d/3-mediated DVL2 phosphorylation. (A) MDA-MB-231 cells were transfected with siCTL or siTAZ, treated with or without
the CK1d/3 inhibitor IC261 for 1 hr, and then treated with control or Wnt3A-conditioned media for 4 hr. Cell lysates were then analyzed by immunoblotting with the
indicated antibodies. (B) MDA-MB-231 cells were transfected with 50 nM siCTL or siTAZ, or 50 nM of total siRNA comprised of combinations of TAZ, CK1d, and
CK13, as indicated. Cells were treated with control or Wnt3A-conditioned media for 4 hr, lysed, and analyzed by immunoblotting.
(C) CK13 knockdown inhibits the enhanced TOPflash activity caused by TAZ knockdown. TOPflash activity was measured in HEK293T cells transfected with the
indicated siRNAs, and then treated with control or Wnt3A-conditioned media. Data from a representative experiment are plotted as the mean of three replicates
plus standard deviation. Knockdown was confirmed by immunoblotting.
(D) TAZ overexpression inhibits the interaction of DVL2 with CK13. HEK293T cells were transfected with T7-DVL2, Flag-TAZ, and decreasing amounts of Flag-
CK13. Interactions were detected by anti-T7 immunoprecipitation followed by anti-Flag immunoblotting. CK13 levels were quantitated with ImageQuant software
(top panel).
(E) A DVL2-binding mutant of TAZ does not inhibit the interaction of DVL2 with CK13. Cells were transfected with Firefly luciferase (Luc) or with CK13 tagged with
Firefly luciferase (CK1-Luc) along with Flag-tagged WT or mutant (1–393, DWW) TAZ. The interaction between DVL2 and CK13 was detected by immunoprecip-
itation of endogenous DVL2 followed by a luciferase assay.
(F) WT TAZ, but not the DVL2-binding mutant nor the nuclear-localized TAZ-S89A, rescue the enhanced Wnt signaling resulting from TAZ knockdown. TOPflash
reporter activity after treatment with control or Wnt3A-conditioned media was measured in HEK293T cells transfected with siCTL or siTAZ expressing low levels
of siRNA-resistant mouse WT Taz, Taz (1-393, DWW), or Taz (S89A). Data from a representative experiment are plotted as the mean of three replicates plus stan-
dard deviation.
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and b-Catenin in the absence of LATS1. As expected, knock-
down of LATS1 in MDA-MB-231 cells led to prominent nuclear
localization of TAZ, whereas, in control conditions, TAZ was
distributed throughout the cell (Figure 6A). Parallel examination
of the localization of b-Catenin revealed increased nuclear accu-
mulation of b-Catenin in siLATS1-transfected cells treated with
Wnt3A (Figure 6A). These results suggest that MST/LATS-medi-584 Developmental Cell 18, 579–591, April 20, 2010 ª2010 Elsevier Iated phosphorylation of TAZ inhibits Wnt/b-Catenin signaling
by retaining TAZ in the cytoplasm, where it inhibits DVL activa-
tion. To explore this further, we examined whether the TAZ-
DVL2 interaction is modulated by LATS1. Indeed, in the absence
of LATS1, the association of TAZ with endogenous DVL2
was reduced (Figure 6B; Figure S6) and concomitantly led
to increased levels of phosphorylated DVL2 (Figure 6C).
Collectively, these data indicate that Hippo signaling regulatesnc.
Figure 5. The MST/LATS Pathway Inhibits Wnt/b-Catenin Signaling
(A) Interaction of endogenous TAZ and LATS1. Cell lysates from MDA-MB-231 cells were subjected to immunoprecipitation with anti-TAZ antibody or control IgG,
and the presence of LATS1 was detected by immunoblotting.
(B) Loss of MST/LATS expression enhances Wnt3A-induced transcriptional responses. TOPflash reporter activity was measured in HEK293T cells transfected
with siRNAs targeting LATS1, LATS2, MST1, or MST2, as indicated, and then incubated with control or Wnt3A-conditioned media. Data from a representative
experiment are plotted as the mean of three replicates plus standard deviation. Immunoblots from total cell lysates were performed to confirm knockdown.
Knockdown of LATS2 was confirmed by RT-PCR (data not shown).
(C) MST/LATS knockdown enhances Wnt3A-dependent AXIN2 expression. The expression of AXIN2 was determined by qPCR from MDA-MB-231 cells trans-
fected with siCTL, siLATS1, or siMST2, and then treated with control or Wnt3A-conditioned media for 4 hr.
(D and E) (D) MST/LATS overexpression inhibits Wnt3A-induced TOPflash activity. HEK293T cells were cotransfected with the TOPflash reporter together with
LATS1 and 0.05 mg or 0.1 mg MST2 or 0.1 mg MST2 (KR) as indicated, and then treated with control or Wnt3A conditioned media. (E) TAZ knockdown suppresses
the inhibitory effect of MST/LATS overexpression on Wnt signaling. HEK293T cells were transfected with the TOPflash reporter, siCTL or siTAZ, and with LATS1
and MST2, and then treated with control or Wnt3A-conditioned media. (D and E) Data from representative experiments are plotted as the mean of three replicates
plus standard deviation.
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DVL2 phosphorylation, to modulate downstream Wnt signaling
events.
The Drosophila Hippo Pathway Regulates Wingless/
Armadillo Signaling
In Drosophila, the Hippo pathway limits organ size, and loss of
the Hippo kinase cascade results in excessive proliferation ofDeveimaginal discs, the adult limb precursors (Harvey et al., 2003;
Huang et al., 2005; Xu et al., 1995). A key role for the Wnt-family
ligand Wg as a morphogen that drives development and
patterning in imaginal discs has been well established (Zecca
et al., 1996). Therefore, to examine modulation of Wnt signaling
by the Hippo pathway in vivo, we employed clonal analysis in
Drosophila, which possess a single Hpo and a single Wts kinase.
First, we confirmed that Yki, the Drosophila homolog of TAZ,lopmental Cell 18, 579–591, April 20, 2010 ª2010 Elsevier Inc. 585
Figure 6. LATS1 Activity Promotes a Cytoplasmic Role for TAZ in the Inhibition of Wnt/b-Catenin Signaling
(A) Abrogation of LATS1 expression induces TAZ nuclear accumulation and stimulates nuclear b-Catenin localization in response to Wnt3A. MDA-MB-231 cells
were transfected with siCTL or siLATS1, and then treated with control or Wnt3A-conditioned media for 2 hr. Cells were then analyzed for endogenous TAZ and
b-Catenin localization by immunofluorescent microscopy. The cell nuclei were visualized by DAPI staining. The scale bar represents 10 mM. The percentage of
cells displaying high nuclear/cytoplasmic variance of b-Catenin signal is shown. Data show that after Wnt3A treatment, siLATS1-treated cells displayed high
nuclear/cytoplasmic variance (p < 0.0001).
(B) TAZ binding to DVL2 is disrupted in the absence of LATS1. MDA-MB-231 cells stably expressing Flag-TAZ were transfected with siCTL or siLATS1. Endog-
enous DVL2 was immunoprecipitated from cell lysates with an anti-DVL2 Fab (see Figure S6), and associated TAZ was analyzed by immunoblotting.
(C) Abrogation of LATS expression enhances Wnt3A-dependent DVL2 phosphorylation. MDA-MB-231 cells were transfected with siCTL or siLATS1 and treated
with control or Wnt3A-conditioned media for 4 hr. Cell lysates were then analyzed by immunoblotting with the indicated antibodies.
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observed for the mammalian counterparts, mapping of the
Dsh-Yki interaction revealed that the PDZ domain and a PY motif
from amino acids 521–525 of Dsh were critical for Yki binding.
The fact that Yki lacks a carboxy-terminal PDZ-binding motif
suggests that Yki contains an internal PDZ-binding domain
similar to that which has been described for other regulators of
the Wnt pathway (London et al., 2004; Wong et al., 2003).
Next, we generated hpo and wts mutant clones in third-instar
wing imaginal discs by using Flp-mediated mitotic recombina-
tion, a site-directed recombination method that generates clonal
mutant tissue adjacent to WT twin spot tissue (Xu and Rubin,
1993). Wg is expressed along the dorsal/ventral (D/V) boundary
in the wing pouch (see Figures S7D and S7E), and the highest
levels of Armadillo (Arm), the Drosophila b-Catenin ortholog,
are typically observed adjacent to this region (Riggleman et al.,
1990). In clones lacking either wts or hpo, as marked by the
absence of GFP, we observed increased Arm protein levels
extending away from the Wg stripe at the D/V boundary, whereas
adjacent GFP-expressing WT twin spots did not (Figure 7A;
Figure S7C). Of note, Arm levels in clones of wts, the direct Yki
kinase, were much higher than those observed in clones of
hpo, indicating that Wts activity is subject to additional regula-586 Developmental Cell 18, 579–591, April 20, 2010 ª2010 Elsevier Itory inputs, as previously suggested (Harvey et al., 2003; Wu
et al., 2003). In addition, the increase in Arm levels was much
less in both wts and hpo mutant clones at the boundary with
WT tissue, an effect that was much more evident as clones
extended away from the D/V boundary and the source of Wg
(Figure 7A; Figure S7C). This might suggest that WT tissue
influences Hippo pathway activity in a non-cell-autonomous
manner to regulate Arm levels, although the precise nature of
these signals is unclear.
To confirm that increased Arm levels were not due to
increased Wg ligand, we examined Wg expression levels in
hpo and wts mutant clones and found no noticeable changes
in Wg levels in the wing pouch region (Figures S7D and S7E),
as previously described (Cho et al., 2006). Thus, the increase
in Arm levels is not due to alterations in expression of the Wg
ligand. We next examined a Wg/Arm target, Distal-less (Dll),
which is normally expressed 20 cells from the D/V boundary
(Zecca et al., 1996). In wts mutant clones, Dll levels were
increased and extended farther from the D/V boundary
(Figure 7B) compared to the WT twin spot tissue. Interestingly,
increased Dll levels were most evident in regions distant from
the D/V boundary, where Wg levels are low. Similarly, we also
observed that Achaete, another Wg target that is expressed innc.
Figure 7. The Drosophila Hippo Pathway Inhibits Wingless Signaling
(A) wts mutant clones have enhanced Arm levels near the D/V boundary in wing imaginal discs. Third-instar wing imaginal discs containing wtsx1 clones, marked
by the absence of GFP, were immunostained with an anti-Arm antibody. A higher-magnification image of the boxed section highlights a clone with enhanced Arm
levels.
(B) The levels of the Wg target, Dll, are enhanced in the outer regions of the wing pouch in wts mutant clones. Third-instar wing imaginal discs containing wtsx1
clones were immunostained with an anti-Dll antibody. A higher magnification image of the outer wing pouch, a region at which Wg levels are low, highlight the
increased levels of Dll in the absence of wts.
(C) The levels of the Wg target, Dll, are decreased in WT Yki-expressing tissue. Third-instar wing imaginal discs expressing WT Yki were immunostained with an
anti-Dll antibody. A higher-magnification image highlights the decreased levels of Dll.
(D) The levels of the Wg target, Dll, are maintained in Yki-S168A-expressing tissue. Third-instar wing imaginal discs expressing the nuclear-localized Yki-S168A
mutant were immunostained with an anti-Dll antibody. A higher-magnification image highlights the unaltered levels of Dll.
(E) A model for Hippo pathway-mediated inhibition of Wnt signaling via TAZ. The Hippo pathway kinases induce the cytoplasmic localization of TAZ, allowing for
an enhanced interaction between TAZ and DVL. TAZ’s interaction with DVL inhibits CK1d/3 binding and Wnt3A-induced DVL phosphorylation, thereby preventing
Wnt3A-induced transcriptional responses. Thus, the Hippo pathway can limit responses to Wnt signals to modulate Wnt-regulated processes.
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increased and extended farther from the D/V boundary in wts
mutant clones (Figure S7B).
Finally, we examined whether the Hpo/Wts target Yki regu-
lates Wg signaling. yki mutant clones are very small, makingDeveanalysis of Wg responses difficult. Therefore, we examined Dll
levels in tissues expressing a WT UAS-Yki transgene (Huang
et al., 2005). This revealed that ectopic expression of WT Yki
resulted in decreased expression of the Wg target Dll (Fig-
ure 7C). To assess whether this effect results from the nuclearlopmental Cell 18, 579–591, April 20, 2010 ª2010 Elsevier Inc. 587
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clones bearing a UAS-Yki(S168A):GFP transgene. Wts is unable
to efficiently phosphorylate this mutant of Yki, which leads to the
localization of Yki primarily in the nucleus (Dong et al., 2007; Oh
and Irvine, 2008). Although this Yki(S168A):GFP transgene,
which expresses a mutant of Yki with reduced cytoplasmic
function, has been shown to yield lower levels of protein than
the WT UAS-Yki transgene we used for this study (Oh and Irvine,
2008), the overgrowth phenotype is similar, indicating that the
nuclear function of Yki(S168A):GFP is comparable to that of
the WT Yki. We found that Dll levels were unchanged in the
Yki(S168A)-expressing clones (Figure 7D), suggesting that cyto-
plasmic Yki inhibits Wg signaling. Altogether, our results indicate
that the Hippo pathway modulates the sensitivity of the cellular
response to morphogens by functioning as a conserved negative
regulator of Wnt/b-Catenin signaling.
DISCUSSION
The Hpo/Wts kinase cascade has emerged as a key regulator of
tissue growth and patterning (Saucedo and Edgar, 2007; Zhao
et al., 2008). This kinase cascade, which in vertebrates is repre-
sented by MST and LATS, respectively, converges on the
transcriptional regulator Yorkie in Drosophila, or the vertebrate
homologs, TAZ and YAP. Recent studies have focused on the
transcriptional roles for Yorkie, TAZ, and YAP in controlling
growth and cell fate choice. However, these proteins are also
found in the cytoplasm, where TAZ has been shown to associate
with the plasma membrane and actin cytoskeleton (Kanai et al.,
2000). TAZ cytoplasmic localization is mediated by LATS-
dependent phosphorylation of serine 89, which drives binding
to the cytoplasmic retention factor, 14-3-3 (Kanai et al., 2000).
Altogether, these findings raised the possibility that TAZ has
cytoplasmic functions. Here, we demonstrate that one such
function is to constrain Wnt signaling by inhibiting CK1d/3-medi-
ated DVL phosphorylation (see model, Figure 7E). Although the
ability of CK1d/3 to phosphorylate DVL has been well estab-
lished, the precise role of this event in Wnt signaling remains to
be fully understood. In our studies, we observed that CK1d/3-
independent signaling can contribute to Wnt-induced b-Catenin
stabilization. Nevertheless, our data clearly show that DVL phos-
phorylation and Wnt pathway activation caused by the loss of
TAZ expression requires CK1d/3. We show that abrogation
of LATS expression, which leads to the nuclear accumulation of
TAZ, reduced TAZ-DVL interaction, enhanced DVL phosphoryla-
tion, and promoted Wnt pathway activation in cells. Furthermore,
we show that loss of hpo orwts function or enhanced expression
of yki in Drosophila wing imaginal discs also modulates Wnt
signaling. Thus, by promoting the cytoplasmic localization of
TAZ, the Hippo pathway not only prevents nuclear TAZ activity,
as previously proposed (Kanai et al., 2000; Lei et al., 2008), but
also leads to inhibition of Wnt signaling by antagonizing DVL acti-
vation. Here, we have focused our studies on TAZ, but it will be
interesting to determine whether the related protein, YAP, has
a similar activity in the Wnt pathway. Indeed, functional redun-
dancy is suggested by theTaz/Yapdouble-knockout mice, which
display early embryonic lethality (Nishioka et al., 2009).
Wnts are known to act throughout mammalian kidney devel-
opment (Merkel et al., 2007), and hyperactivation of Wnt/b-Cat-588 Developmental Cell 18, 579–591, April 20, 2010 ª2010 Elsevier Ienin signaling causes severe kidney defects. For example, loss
of Apc function results in nuclear b-Catenin accumulation that
leads to cystic kidneys (Sansom et al., 2005), and transgenic
mice expressing an activated mutant of b-Catenin also develop
cysts (Saadi-Kheddouci et al., 2001). Taz mutant mice also
develop polycystic kidneys (Hossain et al., 2007; Makita et al.,
2008; Tian et al., 2007), and we found increased cytoplasmic
and nuclear b-Catenin in both cystic and precystic regions of
Tazgt/gt kidneys, indicating Wnt pathway activation. Moreover,
cysts formed in humans with ADPKD, caused by mutations in
PC1 or PC2, display a gene expression profile consistent with
Wnt pathway activation (Lal et al., 2008). b-Catenin associates
with PC1 (Lal et al., 2008), and TAZ has been proposed to indi-
rectly regulate the activity of PC2 via the SCF ubiquitin ligase
b-TrCP (Tian et al., 2007). We confirmed that TAZ and TAZ
(1–393, DWW), the DVL-binding mutant that cannot rescue the
effect of loss of TAZ on Wnt signaling, both interact with
b-TrCP (Figure S3). Thus, we conclude that TAZ modulates
Wnt signaling via direct regulation of DVL; however, TAZ may
also function indirectly to regulate the PC complex via b-TrCP.
Whether TAZ may have other additional roles in Wnt signaling
remains to be determined. Altogether, these results suggest
that, in the kidney, TAZ restricts canonical Wnt signaling that
otherwise would disrupt tubule morphogenesis and the forma-
tion of cysts.
Defects in cilia are also known to be involved in the pathogen-
esis of PKD. Indeed, recent analyses of Taz mutant kidneys
have revealed that Taz localizes to cilia, and that cystic regions
in Taz / kidneys have underdeveloped cilia (Hossain et al.,
2007). Interestingly, primary cilia have recently been implicated
in restraining Wnt signaling (Corbit et al., 2008), and DVL has
been reported in cilia (Park et al., 2008). These findings raise
the intriguing possibility that TAZ may link suppression of DVL
activation in the kidney to ciliogenesis. Of note, we have found
no evidence that the MDA-MB-231 breast cancer cells used in
this study possess cilia (data not shown), indicating that cilia,
per se, are not required for TAZ inhibition of Wnt signaling.
Nevertheless, it will be interesting to examine the relationship
between TAZ regulation of ciliogenesis and DVL modulation in
kidney epithelia.
The development of multicellular organisms requires cell-cell
communication and the coordinated action of distinct signaling
pathways for proper patterning of the body and organs. In the
Drosophila wing imaginal disc, the Wg morphogen gradient
coordinates the expression of an array of developmentally
important genes (Zecca et al., 1996). Our studies reveal that
the Hippo pathway functions to restrain Wg signaling, and that
loss of hpo or wts increases the levels of Arm (b-Catenin) outside
the normal expression domain and enhances expression of Wg
target genes, particularly at a distance from the Wg source.
Thus, Hippo pathway activation may, in effect, serve to restrain
the sensitivity of cells to Wg signals, thus sharpening the Wg
response gradients to promote appropriate tissue patterning
events. How the Hippo kinase cascade is regulated by upstream
pathways remains unclear. However, genetic studies place
a protocadherin, Fat, and an ERM domain protein, Expanded,
upstream of Hpo/Wts kinases (Bennett and Harvey, 2006; Cho
et al., 2006; Hamaratoglu et al., 2006; Silva et al., 2006; Willecke
et al., 2006). Furthermore, and in accordance with our analysis ofnc.
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enhanced Wg target gene expression independent of Wg ligand
production (Tyler and Baker, 2007). Our results suggest that this
occurs via a direct molecular link. In this regard, it is intriguing to
note that mice null for Fat4, a mammalian homolog of Drosophila
fat, also develop polycystic kidneys (Saburi et al., 2008). Direct
communication between the Hippo and Wnt pathways may
thus be an ancient mechanism that coordinates morphogen
signaling with tissue growth control in animals.
We showed that TAZ inhibits Wnt signaling via DVL, providing
for a direct molecular link between the Hippo and Wnt signaling
pathways. Other studies inDrosophila have implicated the Hippo
pathway as a positive regulator of Notch signaling (Meignin et al.,
2007; Yu et al., 2008), and we previously showed an essential
role for TAZ in mediating TGFb-dependent Smad signaling (Var-
elas et al., 2008). Furthermore, TAZ is induced by BMP signaling
to regulate mesenchymal cell differentiation (Hong et al., 2005).
Altogether, these studies suggest a critical and direct role for
TAZ in integrating signals from numerous morphogen signaling
pathways.
EXPERIMENTAL PROCEDURES
Constructs and siRNAs
LATS1, LATS2, MST1, MST2, DVL, CK13, Dsh, and Yki constructs were gener-
ated by PCR and were either triple FLAG-, triple HA-, or Firefly luciferase-
tagged in a pCMV5 vector. TAZ and TAZ mutant cDNA constructs were
described previously (Varelas et al., 2008). siGENOME pools of siRNAs (written
in the 50 to 30 direction) were purchased from Dharmacon, with the follow-
ing exceptions: TAZ single-siRNA (ACGUUGACUUAGGAACUUU); control
(Scrambled TAZ) (UAGUACUGUUACUGGCAUU); and control (invS3) (GGGC
AAGACGAGCGGGAAG).
Transfection, Reporter Assays, and Real-Time Quantitative Reverse
Transcription PCR
HEK293T cells were transfected with calcium phosphate or with Lipofect-
amine 2000 (Invitrogen), and MDA-MB-231 cells were transfected with Dhar-
mafect 4 (Dharmacon). For reporter assays, the HEK293T cells were seeded
in poly-L-lysine-coated 24-well dishes and transfected with cDNAs or siRNAs,
pCMV-b-galactosidase, and either TOPflash or FOPflash reporters. For tran-
scriptional assays, 24 hr after transfection the cells were treated with control
or Wnt3A-conditioned medium for 16 hr. Luciferase activity in cell lysates
was determined and normalized to b-galactosidase activity as previously
described (Labbe et al., 2007). Unless otherwise indicated, siRNAs were
used at a concentration of 50 nM, and cells were lysed 48 hr after transfection.
The quantitation of AXIN2 gene expression by quantitative PCR (qPCR) has
been described previously (Labbe et al., 2007). The DCT values were obtained
by comparing the amplification of the target DNA to that of GAPDH. The quan-
titiation of NKD1 and TNFRSF19 gene expression was qPCR was performed
with the following primers (written in the 50 to 30 direction): NKD1 Forward,
TGAGAAGAAGATGGAGAGAGTGAGCGA; NKD1 Reverse, GGTGACCTTG
CCGTTGTTGTCAAA; TNFRSF19 Forward, GGAGTTGTCTAAGGAATGTGG;
TNFRSF19 Reverse, GCTGAACAATTTGCCTTCTG.
Except where otherwise stated, all graphed data are shown as the mean of
three independent biological replicates plus standard error of the mean (SEM).
All representative experiments shown were reproduced a minimum of three
times.
Immunoprecipitation, LUMIER, and Immunoblotting
Immunoprecipitation (IP) and immunoblotting (IB) were carried out with the
following antibodies: Flag (Sigma #F3165; 1 mg/IP, 1:2000 IB); T7 (Novagen
#69522-3; 1 mg/IP, 1:10,000 IB); HA (Roche #11867431001; 1:1000 IB); TAZ
(BD Biosciences #560235; 3 mg/IP, 1:1000 IB); TAZ (Novus #NB600-220;
1:1000 IB); CK13 (BD Biosciences #610445; 1:2000 IB); b-Catenin (BD Biosci-Deveences #610153; 1:1000 IB); Actin (Sigma # A2066; 1:2000 IB); DVL2 (Cell
Signaling Technology #3224; 1:1000 IB); LATS1 (Bethyl #A300-478A; 1:1000
IB); MST1 (BD biosciences #77120; 1:1000 IB); MST2 (Novus #NB100-
79800; 1:1000 IB). LUMIER experiments were performed as previously
described (Barrios-Rodiles et al., 2005; Varelas et al., 2008). All graphed
data are shown as the mean of three independent biological replicates plus
SEM. For DVL2 IP, a phage display-derived antibody (Fellouse et al., 2007)
selected against human DVL2 was generated, and then validated for its spec-
ificity and pull-down efficiency (Figure S6). The antibody was biotin labeled,
and then bound in excess to streptavidin-conjugated magnetic beads (Prom-
ega #Z5481) that were subsequently blocked with excess free biotin. The
antibody-conjugated beads were then used for immunoprecipitation of
endogenous DVL2 from cell lysates. Biotin-blocked, streptavidin-conjugated
magnetic beads were used as a control.
Immunofluorescence
For immunofluorescent analysis of cell cultures, cells were washed with PBS,
and then fixed with 4% paraformaldehyde. Cells, permeabilized with 0.2%
Triton X-100 in PBS, were blocked with 2% BSA-PBS prior to the addition of
primary antibodies: mouse anti-b-Catenin antibody (BD Biosciences
#610153; 1:1000 in 2% BSA-PBS); rabbit-anti-b-Catenin antibody (Sigma
#C2206; 1:1000 in 2% BSA-PBS); or mouse anti-TAZ antibody (BD Biosci-
ences #560235; 1:500 in 2% BSA-PBS). Secondary antibodies used include:
donkey anti-mouse Alexa Fluor 488 (Invitrogen #A21202; 1:500 in 2% BSA-
PBS) and donkey anti-rabbit Alexa Fluor 555 (Invitrogen #A31572; 1:500 in
2% BSA-PBS). Cell nuclei were visualized by DAPI staining. Quantitatition of
b-Catenin and TAZ nuclear/cytoplasmic localization was performed by using
Image J software. Briefly, tiff images were imported into Image J, and, by using
DAPI staining to mark the cell nuclei, the variance of nuclear to cytoplasmic
b-Catenin or TAZ signal was measured for individual cells. The mean variance
was calculated from a minimum of 310 total cells from 3 different experiments
(with at least 91 and 100 cells counted from each of the control and
Wnt3A-treated experiments, respectively). Cells were then grouped as low
or high nuclear/cytoplasmic depending on whether they fell below or above
the mean variance of the Wnt3A-treated siCTL cells, respectively. An unpaired
two-tailed t test was used to determine the statistical significance. For mouse
kidney analysis, E15, E16, or E17 kidneys were fixed overnight at 4C in 4%
PFA. Samples were then dehydrated, embedded in paraffin, and sectioned
at 5 mM. Sections were boiled in sodium citrate (pH 6.0), incubated with
b-Catenin antibody (BD Biosciences #610153; 1:500), and subsequently
stained with donkey anti-mouse Alexa 555 antibody (Invitrogen #A31570;
1:500). The localization of b-Catenin within the tubules was examined and
scored by using a double-blind analysis, and then grouped as junctional (I),
juntional/cytoplasmic/nuclear (II), or cytoplasmic/nuclear (III). For the analysis
of Drosophila tissues, wing imaginal discs were dissected in PBS with
protease inhibitors and fixed/permeabilized in 4% paraformaldehyde with
0.3% Triton X-100. The samples were then incubated with the following
primary antibodies: mouse anti-Armadillo (Development Studies Hybridoma
Bank #N2-7A1; 1:250), rabbit anti-Distal-less (Sean Carroll; 1:100), mouse
anti-Achaete (Development Studies Hybridoma Bank; 1:10), or mouse
anti-Wingless (Development Studies Hybridoma Bank #4D4; 1:200). The
secondary antibodies used were donkey anti-mouse Alexa 555 (Invitrogen
#A31570; 1:500) or donkey anti-rabbit Alexa 555 (Invitrogen #A31572;
1:500). Images were captured using a spinning disk confocal (Leica) or
a confocal microscope (Nikon).
Drosophila Genetics
Drosophila mutant clones were generated by FLP-FRT-mediated recombina-
tion with wtsx1FRT82B/TM6b (Xu et al., 1995), w; FRT42D hpo42-47CyO
(Wu et al., 2003); yw hs-FLP; FRT42D Ubi-GFP/CyO, and yw hs-FLP;
FRT82B Ubi-GFP. Ectopic expression clones were created by Flip-out with
UAS-Yki (Huang et al., 2005), UAS-Yki-S168A:GFP (Oh and Irvine, 2008),
and yw hs-FLP; act5C > y+ > Gal4 UAS-GFP.
Taz Genetrap Mice
Taz genetrap embryonic stem cells (BayGenomics; CSD245) were used to
generate chimeras by morula aggregation (Wood et al., 1993). Subsequent
germline transmission was confirmed by genotyping, reverse transcriptaselopmental Cell 18, 579–591, April 20, 2010 ª2010 Elsevier Inc. 589
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The Hippo Pathway Regulates Wnt Signaling(RT)-PCR analysis of embryonic RNA, and immunoblotting for Taz from embry-
onic lysates (Figure S2).
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and is available with this
article online at doi:10.1016/j.devcel.2010.03.007.
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